UnitedHealth Group and Humana rose on Friday after TD Cowen upgraded both health insurers to Buy. UnitedHealth traded at $342.71 at 2:29 p.m. Eastern time, up $12.23, or 3.7%, from Thursday’s close of $330.48. Humana was at $394.46, up $14.46, or 3.8%, from $380.00.
Analyst Ryan Langston raised UnitedHealth to Buy from Hold, lifted his price target to $455 from $402 and named it a best idea for 2027, according to Investing.com and Yahoo Finance. He pointed to more rational 2027 Medicare Advantage benefit designs, a multi-year recovery at the Optum Health unit and improving commercial and Medicaid margins. TD Cowen also raised Humana to Buy from Hold and lifted its price target to $485 from $430.
The gains recover only part of a steep drop. UnitedHealth fell 19.8% from Monday’s close of $412.02 to Thursday’s, and Humana fell 17.6% from $461.25, as a proposed federal effort to curb fraud raised worries about more audits of Medicare Advantage insurers and repayments of improper payments. TD Cowen called that risk manageable, Yahoo Finance reported.
…
That’s the story. … Thank you for listening to Cedar Global Markets. We’re supported by our partners, and you can learn more about the partner featured on this page. We’ll see you next time.




